SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $222,715 | -26.9% | 7,409 | -11.9% | 0.01% | -37.5% |
| Q1 2023 | $304,549 | +10.7% | 8,406 | +9.0% | 0.01% | +14.3% |
| Q4 2022 | $275,051 | -8.6% | 7,711 | -13.2% | 0.01% | 0.0% |
| Q3 2022 | $301,000 | +157.3% | 8,886 | +122.2% | 0.01% | +600.0% |
| Q4 2021 | $117,000 | -89.5% | 4,000 | -90.5% | 0.00% | -90.9% |
| Q3 2021 | $1,119,000 | -36.5% | 41,962 | -26.7% | 0.01% | -35.3% |
| Q2 2021 | $1,763,000 | +4000.0% | 57,251 | +3246.1% | 0.02% | +1600.0% |
| Q4 2020 | $43,000 | -96.9% | 1,711 | -97.4% | 0.00% | -96.2% |
| Q3 2020 | $1,379,000 | – | 66,177 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |